TONGE
v.
NOVARTIS PHARMACEUTICALS CORPORATION
AI-generated. These summaries, headnotes, and key points are machine-generated and may contain errors or omissions. Always verify against the full opinion text below. Not legal advice.
A complaint need not plead facts to negate an affirmative defense like the statute of limitations, and a motion to dismiss is inappropriate when resolution depends on facts not yet in evidence.
Plaintiff sued Novartis for injuries sustained after taking a drug, alleging failure to warn of dangerous risks. Defendant moved to dismiss, arguing t…
The full statement of facts, procedural history, and disposition for this case are member content.
Join FLexlaw to unlock all legal intelligence© FLexlaw, Inc. — AI-generated enrichments are proprietary. All rights reserved.
Explore caselaw by topic → Browse Tolling Agreement cases and more on FLexlaw
Defendant. /
OPINION AND ORDER1
Before the Court is Defendant Novartis Pharmaceuticals Corp.’s Motion to Dismiss or in the Alternative, Motion for More Definite Statement (Doc. 9), Plaintiff Ronald Tonge’s response in opposition (Doc. 11), and Defendant’s reply (Doc. 15). For the reasons below, the motion is denied.
BACKGROUND
This is a products liability case. Plaintiff sues Defendant for injuries he sustained after taking a Novartis drug that treats leukemia. According to the Complaint, Defendant failed to warn of the drug’s dangerous and known risks. The Complaint details Defendant’s marketing tactics and its knowledge, concealment, and intentional failure to warn of the drug’s risks. It also pleads facts about Plaintiff and his injury, such as him (1) being diagnosed with leukemia in 2009; (2) taking the drug from February 2011 to June 2014; and (3) later developing peripheral vascular disease that led to more procedures
LEGAL STANDARDS
Rule 12(b)(6) allows a complaint to be dismissed for failing to state a claim upon which relief can be granted. To survive a motion to dismiss, “a complaint must contain sufficient factual matter, accepted as true, to state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). A claim is facially plausible when the complaint’s factual content allows the court to draw a reasonable inference that the defendant is liable for the alleged misconduct. Id. A party must plead more than “labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007) (citations omitted). And when deciding a motion to dismiss, the court must accept all factual allegations in the complaint as true and view them in a light most favorable to the plaintiff. Ashcroft, 556 U.S. at 679. It is well settled that “[a] statute of limitations bar is an affirmative defense and plaintiffs are not required to negate an affirmative defense in their complaint.” Beach Comm. Bank v. CBG Real Estate LLC, 674 F. App’x 932, 934 (11th Cir. 2017) (citing La
Grasta v. First Union Sec., Inc., 358 F. 3d 840, 845 (11th Cir. 2004)). Courts thus grant a motion to dismiss on statute of limitations grounds “only if it is apparent from the face of the complaint that the claim is time-barred.” Id. at 934 (citation omitted). And “a motion to dismiss on statute of limitations grounds should not be granted where resolution depends either on facts not yet in evidence or on construing factual ambiguities in the complaint in defendant’s favor.” Clements v. 3M Elec. Monitoring, No. 2:16-CV-776-FTM- 38CM, 2017 WL 4326618, at *2 (M.D. Fla. June 29, 2017) (citing Omar ex rel. Cannon v. Lindsey, 334 F. 3d 1246, 1252 (11th Cir. 2003)).
DISCUSSION
After considering the parties’ arguments, record, and applicable law, the Court denies the motion. Defendant argues the date of injury is essential to the Complaint’s product liability claims. The Court disagrees. This date is critical to Defendant’s statute of limitations defense, not the underlying claims to which that defense applies. Florida law allows a four-year statute of limitations for personal injury claims arising from product defects.2 Fla. Stat. § 95.11(3)(e). This period runs “from the date that the facts giving rise to the cause of action were discovered, or should have been discovered with the exercise of due diligence.” Id. § 95.031(2)(b). Put differently,
Plaintiff’s product liability claims are time-barred. To resolve the statute of limitations defense, Defendant asks the Court to consider a doctor’s note dated November 21, 2013 that identifies a peripheral vascular disease diagnosis, which Defendant attached to its motion to dismiss. The Court would then need to view that note in Defendant’s favor to imply that Plaintiff was aware of the diagnosis and a possible connection between his injury and the drug. This logical chain is several links too long for this preliminary stage. See Beach Comm., 674 F. App’x at 935 (reversing the district court’s dismissal based on a statute of limitations defense because “a more developed factual record” was needed to decide “whether and when [the plaintiff] should have discovered [the defendant’s] fraud”); see also Carter v. Brown & Williamson Tobacco Corp., 778 So. 2d 932, 936-37 (Fla. 2000) (stating a products liability cause of action involving a latent disease “accrues when the accumulated effects of the deleterious substance manifest themselves to the claimant in a way which supplies some evidence of a causal relationship to the manufactured product” (citation omitted)). Plus, Plaintiff raises a possible tolling agreement between the parties. At bottom, Defendant’s statute of limitations argument is better suited for summary judgment. Defendant’s alternative request for a more definite statement under Fed. R. Civ. P. 12(e) fares no better. A defendant may move for a more definite statement when a complaint “is so vague or ambiguous that the party cannot reasonably prepare a response.” Fed. R. Civ. P. 12(e). Motions for more definite statements are “disfavored under the law” and are “not to be used as a substitute for discovery.” Spiral Direct, Inc. v. Basic Sports Apparel, Inc., 151 F. Supp. 3d 1268, 1281-82 (M.D. Fla. 2015) (citation omitted). “The motion is intended to provide a remedy for an unintelligible pleading, rather than a vehicle for obtaining greater detail.” Advanta-Star Auto. Research Corp. of Am. v. Semoran Auto Acquisitions, Inc., No. 6:17-cv-1675-Orl-40GJK, 2018 WL 1907643, at *3 n.5 (M.D. Fla. Apr. 23, 2018) (citation omitted). The Complaint alleges two product liability claims because of Defendant’s drug that Plaintiff took for his leukemia. Defendant thus knows the claims and the basic supporting facts. Because Defendant can reasonably prepare a response, a more definite statement is unnecessary. Accordingly, it is now ORDERED: (1) Defendant Novartis Pharmaceuticals Corp.’s Motion to Dismiss or in the Alternative, Motion for More Definite Statement (Doc. 9) is DENIED. (2) Defendant must answer the Complaint on or before June 18, 2020. DONE and ORDERED in Fort Myers, Florida this 4th day of June 2020.
,
UNITED STATES DISTRICT JUDGE
Copies: All Parties of Record
Cases With Similar Vibessemantic neighbors from the corpus
Citator
Authorities Cited
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (U.S. 2007)
- Ashcroft v. Iqbal, 556 U.S. 662 (U.S. 2009)
- La Grasta v. First Union Sec., Inc., 358 F.3d 840 (11th Cir. 2004)
- Univ. OF Miami v. Bogorff, 583 So. 2d 1000 (Fla. 1991)
- Grady Carter v. Brown & Williamson Tobacco Corp., 778 So. 2d 932 (Fla. 2000)
- Omar v. Lindsey, 334 F.3d 1246 (11th Cir. 2003)
- Horowitch v. Diamond Aircraft Indus., Inc., 645 F.3d 1254 (11th Cir. 2011)
- Colville v. Pharmacia & Upjohn Co. LLC, 565 F. Supp. 2d 1314 (N.D. Fla. 2008)